According to the research report published by Market IntelliX, the global market for Pharmaceutical Activated Carbon should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
Activated charcoal has been used as an oral medicine for a long time, and in the rescue and treatment of patients with acute transoral poisoning, medicinal activated charcoal is one of the important basic rescue measures, which can obviously reduce the absorption of poison and increase the excretion and removal of poison, and obviously improve the success rate of rescue of patients with transoral poisoning. Oral administration of activated carbon is an effective method to reduce the absorption of poisons taken by patients. As an excellent adsorbent material, activated carbon is not only used for oral adsorption and detoxification in emergency medicine, but also widely used as a blood perfusion adsorbent for artificial organ adsorption preparations, for specific central nervous system, for treating certain previously incurable diseases, and in recent years it has also been used as a drug carrier for solutes, for treating malignant tumors Lymph nodes, for guiding the removal of metastatic lymph nodes, and for adjust the pore size of activated carbon and its distribution so that it can absorb various harmful substances and bacteria.
Units: The units in this report refer to the basic quantity units of statistics, such as tablets (Changtian Pharmaceuticals) for the tablet type, and capsules and pills for the pill type, such as Wuxi Ji Yu Shanhe Pharmaceuticals. The unit of product for bag type or granule type is bag.
The key manufacturers of pharmaceutical activated carbon in the Chinese market are Jemincare, Changtian Pharma, Kureha, Myvitamins, etc. The top two manufacturers account for 99% of the market share, with the largest manufacturer being Jemincare with 89%. Production areas are mainly located in Europe, China, Japan, etc. In terms of product type, activated carbon tablets/granules occupy the major market share, accounting for 90%, followed by activated carbon capsules, accounting for about 10%. In terms of application, the pharmacy channel is the top application area, accounting for 70% of the total, while the prescription channel accounts for 28%.
This report studies and analyses global Pharmaceutical Activated Carbon status and future trends, helps the client to determine the Pharmaceutical Activated Carbon market size of the total market opportunity by Type, by Distribution Channel, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Activated Carbon, and provides market size (in M Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pharmaceutical Activated Carbon market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (M Units)
(2) Global Pharmaceutical Activated Carbon sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Units)
(3) China Pharmaceutical Activated Carbon sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (M Units)
(4) Global Pharmaceutical Activated Carbon key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pharmaceutical Activated Carbon key producing regions, capacity, production, and year over year growth
(6) Pharmaceutical Activated Carbon industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Jemincare
Changtian Pharma
Kureha
Myvitamins
Market segment by Type, covers
Pharmaceutical Activated Carbon Capsule
Pharmaceutical Activated Carbon Tablet
Others
Market segment by Distribution Channel, can be divided into
Drug Stores
Prescription Drug
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pharmaceutical Activated Carbon product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pharmaceutical Activated Carbon market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Pharmaceutical Activated Carbon market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Pharmaceutical Activated Carbon, percent & CAGR, 2018-2029
Chapter 5: Pharmaceutical Activated Carbon industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pharmaceutical Activated Carbon Definition
1.2 Global Pharmaceutical Activated Carbon Market Size and Forecast
1.2.1 By Consumption Value, Global Pharmaceutical Activated Carbon Market Size,2018-2029
1.2.2 By Sales Quantity, Global Pharmaceutical Activated Carbon Market Size,2018-2029
1.2.3 Global Pharmaceutical Activated Carbon Average Selling Price (ASP),2018-2029
1.3 China Pharmaceutical Activated Carbon Market Size and Forecast
1.3.1 By Consumption Value, China Pharmaceutical Activated Carbon Market Size,2018-2029
1.3.2 By Sales Quantity, China Pharmaceutical Activated Carbon Market Size,2018-2029
1.3.3 China Pharmaceutical Activated Carbon Average Selling Price (ASP), 2018-2029
1.4 Share of China Pharmaceutical Activated Carbon Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pharmaceutical Activated Carbon Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Pharmaceutical Activated Carbon Market Share in Global, 2018-2029
1.4.3 Pharmaceutical Activated Carbon Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical Activated Carbon Market Dynamics
1.5.1 Pharmaceutical Activated Carbon Market Drivers
1.5.2 Pharmaceutical Activated Carbon Market Restraints
1.5.3 Pharmaceutical Activated Carbon Industry Trends
1.5.4 Pharmaceutical Activated Carbon Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pharmaceutical Activated Carbon, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Pharmaceutical Activated Carbon, Global Market Share by Company, 2018-2023
2.3 Pharmaceutical Activated Carbon Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Pharmaceutical Activated Carbon Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Activated Carbon Concentration Ratio
2.6 Global Pharmaceutical Activated Carbon Mergers & Acquisitions, Expansion Plans
2.7 Global Pharmaceutical Activated Carbon Manufacturers Product Type
2.8 Head Office and Pharmaceutical Activated Carbon Production Site of Key Manufacturer
2.9 Pharmaceutical Activated Carbon Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pharmaceutical Activated Carbon, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Pharmaceutical Activated Carbon, China Market Share by Company, 2018-2023
3.3 China Pharmaceutical Activated Carbon Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pharmaceutical Activated Carbon Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Pharmaceutical Activated Carbon Capacity by Region
4.3 Global Pharmaceutical Activated Carbon Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Pharmaceutical Activated Carbon Production by Region, 2018-2029
4.5 Global Pharmaceutical Activated Carbon Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pharmaceutical Activated Carbon Industry Chain
5.2 Pharmaceutical Activated Carbon Upstream Analysis
5.2.1 Pharmaceutical Activated Carbon Core Raw Materials
5.2.2 Main Manufacturers of Pharmaceutical Activated Carbon Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pharmaceutical Activated Carbon Production Mode
5.6 Pharmaceutical Activated Carbon Procurement Model
5.7 Pharmaceutical Activated Carbon Industry Sales Model and Sales Channels
5.7.1 Pharmaceutical Activated Carbon Sales Model
5.7.2 Pharmaceutical Activated Carbon Typical Distributors
6 Sights by Type
6.1 Pharmaceutical Activated Carbon Classification
6.1.1 Pharmaceutical Activated Carbon Capsule
6.1.2 Pharmaceutical Activated Carbon Tablet
6.1.3 Others
6.2 By Type, Global Pharmaceutical Activated Carbon Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029
6.4 By Type, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029
6.5 By Type, Global Pharmaceutical Activated Carbon Average Selling Price (ASP), 2018-2029
7 Sights by Distribution Channel
7.1 Pharmaceutical Activated Carbon Segment by Distribution Channel
7.1.1 Drug Stores
7.1.2 Prescription Drug
7.2 By Distribution Channel, Global Pharmaceutical Activated Carbon Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Distribution Channel, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029
7.4 By Distribution Channel, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029
7.5 By Distribution Channel, Global Pharmaceutical Activated Carbon Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pharmaceutical Activated Carbon Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029
8.3 By Region, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Pharmaceutical Activated Carbon & Forecasts, 2018-2029
8.4.2 By Country, North America Pharmaceutical Activated Carbon Market Size Market Share
8.5 Europe
8.5.1 Europe Pharmaceutical Activated Carbon Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pharmaceutical Activated Carbon Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pharmaceutical Activated Carbon Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pharmaceutical Activated Carbon Market Size Market Share
8.7 South America
8.7.1 South America Pharmaceutical Activated Carbon Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pharmaceutical Activated Carbon Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pharmaceutical Activated Carbon Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029
9.3 By Country, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Pharmaceutical Activated Carbon Market Size, 2018-2029
9.4.2 By Type, U.S. Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Distribution Channel, U.S. Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pharmaceutical Activated Carbon Market Size, 2018-2029
9.5.2 By Type, Europe Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Distribution Channel, Europe Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Pharmaceutical Activated Carbon Market Size, 2018-2029
9.6.2 By Type, China Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Distribution Channel, China Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pharmaceutical Activated Carbon Market Size, 2018-2029
9.7.2 By Type, Japan Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Distribution Channel, Japan Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pharmaceutical Activated Carbon Market Size, 2018-2029
9.8.2 By Type, South Korea Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Distribution Channel, South Korea Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pharmaceutical Activated Carbon Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Distribution Channel, Southeast Asia Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Pharmaceutical Activated Carbon Market Size, 2018-2029
9.10.2 By Type, India Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Distribution Channel, India Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pharmaceutical Activated Carbon Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Distribution Channel, Middle East & Africa Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Jemincare
10.1.1 Jemincare Company Information, Head Office, Market Area, and Industry Position
10.1.2 Jemincare Pharmaceutical Activated Carbon Models, Specifications, and Application
10.1.3 Jemincare Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Jemincare Company Profile and Main Business
10.1.5 Jemincare Recent Developments
10.2 Changtian Pharma
10.2.1 Changtian Pharma Company Information, Head Office, Market Area, and Industry Position
10.2.2 Changtian Pharma Pharmaceutical Activated Carbon Models, Specifications, and Application
10.2.3 Changtian Pharma Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Changtian Pharma Company Profile and Main Business
10.2.5 Changtian Pharma Recent Developments
10.3 Kureha
10.3.1 Kureha Company Information, Head Office, Market Area, and Industry Position
10.3.2 Kureha Pharmaceutical Activated Carbon Models, Specifications, and Application
10.3.3 Kureha Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Kureha Company Profile and Main Business
10.3.5 Kureha Recent Developments
10.4 Myvitamins
10.4.1 Myvitamins Company Information, Head Office, Market Area, and Industry Position
10.4.2 Myvitamins Pharmaceutical Activated Carbon Models, Specifications, and Application
10.4.3 Myvitamins Pharmaceutical Activated Carbon Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Myvitamins Company Profile and Main Business
10.4.5 Myvitamins Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pharmaceutical Activated Carbon Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pharmaceutical Activated Carbon Market Restraints
Table 3. Pharmaceutical Activated Carbon Market Trends
Table 4. Pharmaceutical Activated Carbon Industry Policy
Table 5. Global Pharmaceutical Activated Carbon Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Pharmaceutical Activated Carbon Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Pharmaceutical Activated Carbon Sales Quantity by Company, (2018-2023) & (M Units), Ranked Based on Sales in 2022
Table 8. Global Pharmaceutical Activated Carbon Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Pharmaceutical Activated Carbon Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Pharmaceutical Activated Carbon Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pharmaceutical Activated Carbon Mergers & Acquisitions, Expansion Plans
Table 12. Global Pharmaceutical Activated Carbon Manufacturers Product Type
Table 13. Head Office and Pharmaceutical Activated Carbon Production Site of Key Manufacturer
Table 14. Pharmaceutical Activated Carbon Capacity of Major Manufacturers and Future Plan
Table 15. China Pharmaceutical Activated Carbon Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Pharmaceutical Activated Carbon Sales Quantity by Company, (2018-2023) & (M Units), Ranked Based on Sales in 2022
Table 17. China Pharmaceutical Activated Carbon Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Pharmaceutical Activated Carbon Production & Forecast by Region, 2018 VS 2022 VS 2029, (M Units)
Table 19. Global Pharmaceutical Activated Carbon Production by Region, 2018-2023, (M Units)
Table 20. Global Pharmaceutical Activated Carbon Production Forecast by Region, 2024-2029, (M Units)
Table 21. Global Key Players of Pharmaceutical Activated Carbon Upstream (Raw Materials)
Table 22. Global Pharmaceutical Activated Carbon Typical Customers
Table 23. Pharmaceutical Activated Carbon Typical Distributors
Table 24. By Type, Global Pharmaceutical Activated Carbon Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Distribution Channel, Global Pharmaceutical Activated Carbon Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Pharmaceutical Activated Carbon Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Table 29. By Country, Global Pharmaceutical Activated Carbon Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Pharmaceutical Activated Carbon Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Table 33. By Country, Global Pharmaceutical Activated Carbon Sales Quantity Market Share, 2018-2029
Table 34. Jemincare Company Information, Head Office, Market Area, and Industry Position
Table 35. Jemincare Pharmaceutical Activated Carbon Models, Specifications, and Application
Table 36. Jemincare Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. Jemincare Company Profile and Main Business
Table 38. Jemincare Recent Developments
Table 39. Changtian Pharma Company Information, Head Office, Market Area, and Industry Position
Table 40. Changtian Pharma Pharmaceutical Activated Carbon Models, Specifications, and Application
Table 41. Changtian Pharma Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Changtian Pharma Company Profile and Main Business
Table 43. Changtian Pharma Recent Developments
Table 44. Kureha Company Information, Head Office, Market Area, and Industry Position
Table 45. Kureha Pharmaceutical Activated Carbon Models, Specifications, and Application
Table 46. Kureha Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Kureha Company Profile and Main Business
Table 48. Kureha Recent Developments
Table 49. Myvitamins Company Information, Head Office, Market Area, and Industry Position
Table 50. Myvitamins Pharmaceutical Activated Carbon Models, Specifications, and Application
Table 51. Myvitamins Pharmaceutical Activated Carbon Sales Quantity (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Myvitamins Company Profile and Main Business
Table 53. Myvitamins Recent Developments
List of Figures
Figure 1. Pharmaceutical Activated Carbon Picture
Figure 2. Global Pharmaceutical Activated Carbon Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Pharmaceutical Activated Carbon Sales Quantity, (M Units) & (2018-2029)
Figure 4. Global Pharmaceutical Activated Carbon Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Pharmaceutical Activated Carbon Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Pharmaceutical Activated Carbon Sales Quantity (M Units) & (2018-2029)
Figure 7. China Pharmaceutical Activated Carbon Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Pharmaceutical Activated Carbon Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Pharmaceutical Activated Carbon Market Share of Global, 2018-2029
Figure 10. Global Pharmaceutical Activated Carbon Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Pharmaceutical Activated Carbon Key Participants, Market Share, 2022
Figure 12. Global Pharmaceutical Activated Carbon Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Pharmaceutical Activated Carbon Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Pharmaceutical Activated Carbon Production Market Share & Forecast by Region, 2018-2029
Figure 15. Pharmaceutical Activated Carbon Industry Chain
Figure 16. Pharmaceutical Activated Carbon Procurement Model
Figure 17. Pharmaceutical Activated Carbon Sales Model
Figure 18. Pharmaceutical Activated Carbon Sales Channels, Direct Sales, and Distribution
Figure 19. Pharmaceutical Activated Carbon Capsule
Figure 20. Pharmaceutical Activated Carbon Tablet
Figure 21. Others
Figure 22. By Type, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029, US$ Million
Figure 23. By Type, Global Pharmaceutical Activated Carbon Consumption Value Market Share, 2018-2029
Figure 24. By Type, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 25. By Type, Global Pharmaceutical Activated Carbon Sales Quantity Market Share, 2018-2029
Figure 26. By Type, Global Pharmaceutical Activated Carbon Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 27. Drug Stores
Figure 28. Prescription Drug
Figure 29. By Distribution Channel, Global Pharmaceutical Activated Carbon Consumption Value, 2018-2029, US$ Million
Figure 30. By Distribution Channel, Global Pharmaceutical Activated Carbon Consumption Value Market Share, 2018-2029
Figure 31. By Distribution Channel, Global Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 32. By Distribution Channel, Global Pharmaceutical Activated Carbon Sales Quantity Market Share, 2018-2029
Figure 33. By Distribution Channel, Global Pharmaceutical Activated Carbon Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 34. By Region, Global Pharmaceutical Activated Carbon Consumption Value Market Share, 2018-2029
Figure 35. By Region, Global Pharmaceutical Activated Carbon Sales Quantity Market Share, 2018-2029
Figure 36. North America Pharmaceutical Activated Carbon Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 37. By Country, North America Pharmaceutical Activated Carbon Consumption Value Market Share, 2022
Figure 38. Europe Pharmaceutical Activated Carbon Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 39. By Country, Europe Pharmaceutical Activated Carbon Consumption Value Market Share, 2022
Figure 40. Asia Pacific Pharmaceutical Activated Carbon Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 41. By Country/Region, Asia Pacific Pharmaceutical Activated Carbon Consumption Value Market Share, 2022
Figure 42. South America Pharmaceutical Activated Carbon Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 43. By Country, South America Pharmaceutical Activated Carbon Consumption Value Market Share, 2022
Figure 44. Middle East & Africa Pharmaceutical Activated Carbon Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 45. U.S. Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 46. By Type, U.S. Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 47. By Distribution Channel, U.S. Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 48. Europe Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 49. By Type, Europe Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 50. By Distribution Channel, Europe Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 51. China Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 52. By Type, China Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 53. By Distribution Channel, China Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 54. Japan Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 55. By Type, Japan Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 56. By Distribution Channel, Japan Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 57. South Korea Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 58. By Type, South Korea Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 59. By Distribution Channel, South Korea Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 60. Southeast Asia Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 61. By Type, Southeast Asia Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 62. By Distribution Channel, Southeast Asia Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 63. India Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 64. By Type, India Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 65. By Distribution Channel, India Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 66. Middle East & Africa Pharmaceutical Activated Carbon Sales Quantity, 2018-2029, (M Units)
Figure 67. By Type, Middle East & Africa Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 68. By Distribution Channel, Middle East & Africa Pharmaceutical Activated Carbon Sales Quantity Market Share, 2022 VS 2029
Figure 69. Research Methodology
Figure 70. Breakdown of Primary Interviews
Figure 71. Bottom-up and Top-down Approaches
Figure 72. Top-down Approaches
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|